Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in

J H Moffitt1, B A Fielding, R Evershed

  • 1Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, OX3 7LJ, UK.

Diabetologia
|August 12, 2005
PubMed
Abstract

Insights

Saturated fatty acids like palmitic acid induce beta cell death in vitro by forming solid triglycerides in the endoplasmic reticulum. This lipotoxicity, driven by physicochemical properties, may be an artifact of in vitro conditions rather than a factor in obesity-related diabetes.

Area of Science:

  • Cell biology
  • Endocrinology
  • Metabolic disease research

Background:

  • Long-term exposure to lipids, especially saturated fatty acids, causes beta cell dysfunction and apoptosis (lipotoxicity).
  • This lipotoxicity may contribute to obesity-related diabetes.
  • Understanding the relationship between cell death and intracellular lipid accumulation is crucial.

Purpose of the Study:

  • To investigate the link between cell death and intracellular triglyceride concentration, composition, and localization.
  • To examine the effects of saturated and unsaturated non-esterified fatty acids (NEFA) on INS1 cells under varying glucose conditions.

Main Methods:

  • INS1 cells were cultured with palmitic, oleic, or linoleic acids at different glucose concentrations.
  • Intracellular lipids were analyzed using gas chromatography and microscopy.
  • Cell death was quantified using microscopy and MTT assays; insulin secretion was measured by ELISA.

Main Results:

  • Palmitic acid induced significant cytotoxicity and apoptosis, forming solid tripalmitin triglycerides within the endoplasmic reticulum.
  • Unsaturated fatty acids reduced cytotoxicity and morphological disruption.
  • All NEFA inhibited glucose-stimulated insulin secretion, with triglyceride content increasing up to 10-fold.

Conclusions:

  • The physicochemical properties of tripalmitin, formed from palmitic acid in the endoplasmic reticulum, likely trigger apoptosis.
  • Lipid-induced beta cell apoptosis may be primarily an in vitro phenomenon due to the formation of single-species triglycerides.
  • These findings suggest that saturated fatty acid-induced beta cell destruction might be an artifact of in vitro experimental conditions.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...